Topics

Glioblastoma | Treatment | Clinical trials | Molecular Glioblastoma

Home > Publications > Topics > Glioblastoma > Treatment > Clinical trials > Molecular Glioblastoma

Yeboa DN, Whitfield BT, Lin R, Ejezie CL, Swanson TA, Beckham TH, Wang C, De B, Perni S, Tom MC, Li J, McGovern SL, Harrison R, Majd NK, Puduvalli VK, Aaroe AE, Loghin M, O'Brien BJ, Patel AD, Patel CB, Wefel JS, Taslicay CA, Gule-Monroe M, Paulino AC, McAleer MF, Grosshans DR, Ghia AJ, Jiang W, Chung C, Maor M, Yang CH, Gubbiotti MA, Kamiya-Matsuoka C, Ballester LY, Weathers SP, Huse JT.
Prospective phase II clinical trial of molecular glioblastoma (historical grade 2 and 3 IDH wildtype gliomas) preliminary novel exploratory analyses: Treatment intensification, margin reduction and epigenetic stratified outcomes with radiation therapy and chemotherapy.
J Neurooncol. 2025 Nov 5;176(1):72. doi: 10.1007/s11060-025-05269-6. PMID: 41191157. Interventional study. ˍ